User: Guest

CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS

Global Market Trajectory & Analytics

MCP-7869

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

2011
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

362
Interactions with Platform & by Email

PARTICIPANTS

62
Unique # Participated

VALIDATIONS

28
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

108

PAGES

186

EDITION

18

PRICE

USD $5450


Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.
The Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.4% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.
In the global CTC Analysis segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.3 Billion by the year 2027.We bring years of research experience to this 18th edition of our report. The 186-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
ApoCell, Inc.; Biocep Ltd.; Biocept, Inc.; Biofluidica Microtechnologies LLC; Celltraffix Inc.; Clearbridge Biomedics; Creatv Microtech, Inc.; Cynvenio Biosystems, Inc.; Fluxion Biosciences, Inc.; Ikonisys, Inc.; IVDiagnostics, Inc.; Janssen Diagnostics LLC; QIAGEN Hannover GmbH; Rarecells Sas; Screencell; Stemcell Technologies, Inc.
» Technology (CTC Enrichment Methods, CTC Detection Methods, CTC Analysis) » Application (Cancer Stem Cell Research, EMT Biomarkers Development, Tumorgenesis Research, Other Applications)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Market Outlook
Recent Market Activity
Clinical Relevance of CTCs
CTC Detection - Real-Time 'Liquid Biopsy' Scores Over Surgical Biopsy
Major Challenges in CTC Diagnostics
Need for CTC Enrichment and Popular Methods
CTC Enrichment Techniques
Select Available CTC Detection Technologies
Select CTC Isolation Systems - A Brief Comparison
CTC Identification - Various Approaches
CTC Identification Approaches
List of mRNA Markers for RT-PCRbased Detection of CTCs by Tumor Type
CellSearch System - The First FDA Approved Automated Enrichment/Isolation Technique
Rising Incidence of Cancer - An Opportunity Indicator
Cancer Prone Sites based on Age
Global Competitor Market Shares
Circulating Tumor Cell (CTC) Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
ApoCell, Inc. (US)
Biocep Ltd. (Israel)
Biocept, Inc. (US)
Biofluidica Microtechnologies LLC (US)
Celltraffix Inc. (US)
Clearbridge Biomedics (Singapore)
Creatv Microtech, Inc. (US)
Cynvenio Biosystems, Inc. (US)
Epic Biosciences Inc. (US)
Fluxion Biosciences, Inc. (US)
Ikonisys, Inc. (US)
IVDiagnostics, Inc. (US)
Janssen Diagnostics LLC (US)
QIAGEN Hannover GmbH (Germany)
RARECELLS SAS (Italy)
ScreenCell (France)
STEMCELL Technologies, Inc. (Canada)
3. MARKET TRENDS & DRIVERS
Liquid Biopsy - the New Buzzword in Healthcare
Select Companies Active in Cancer Liquid Biopsy
CTCs for Personalized Cancer Treatment
Microfluidic Chip-based Technologies - A Promising Avenue for Cancer Diagnosis
CTC Microdevices Hog the Limelight
Increasing Research Reveal Further Complexities to CTC Composition and Behavior
EpCAM Glycoprotein - Insufficient for CTC Detection
New Isolation Techniques Show Promise in Detecting EpCAM-Negative CTCs
Physical Property-based Enrichment Technologies Lose Fizz
Evidence in Favor CTC Heterogeneity Gains Strength
CTC Clusters Raise Research Interest
Detection of EMTs Gains Precedence in the Backdrop of Recent Research Findings
Limitations of CTC Technology for Point-of-Care Testing
CTC Technologies Offer an Edge over Imaging Tests for Breast Cancer Prognosis
Limited Biomarkers Utilized In CTC Diagnostics - A Threat to Market Growth?
Select Research Findings in Recent Years
Microfluidic Device with Micro-Hall Sensors Detect CTCs with Higher Sensitivity and Specificity
NBiomics Makes its Contribution to CTC Diagnosis
Researchers at University of Michigan Develop Revolutionary Capture CTCs Method
Dean Flow Fractionation to Overcome Limitations Associated with Conventional Biomarker Analysis
Gold Nanoparticles Help in the Detection of CTCs
4. GLOBAL MARKET PERSPECTIVE
Circulating Tumor Cell (CTC) Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
CTC Enrichment Methods (Technology) World Market by Region/Country in US$ Million: 2018 to 2025
CTC Enrichment Methods (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
CTC Enrichment Methods (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
CTC Detection Methods (Technology) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
CTC Detection Methods (Technology) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
CTC Detection Methods (Technology) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
CTC Analysis (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
CTC Analysis (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
CTC Analysis (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Cancer Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
Cancer Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
Cancer Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
EMT Biomarkers Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
EMT Biomarkers Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
EMT Biomarkers Development (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
Tumorgenesis Research (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
Tumorgenesis Research (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
Tumorgenesis Research (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Circulating Tumor Cell (CTC) Diagnostics Market Share (in %) by Company: 2018 & 2025
Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million in the United States by Technology: 2018-2025
United States Circulating Tumor Cell (CTC) Diagnostics Market Retrospective Analysis in US$ Million by Technology: 2009-2017
United States Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
United States Circulating Tumor Cell (CTC) Diagnostics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
Circulating Tumor Cell (CTC) Diagnostics Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
Canada
Circulating Tumor Cell (CTC) Diagnostics Market Analysis in Canada in US$ Million by Technology: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017
Canadian Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
Canadian Circulating Tumor Cell (CTC) Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
Circulating Tumor Cell (CTC) Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
Canadian Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2009 VS 2019 VS 2025
Japan
Japanese Medium & Long-Term Outlook for Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Technology: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Japan in US$ Million by Technology: 2009-2017
Japanese Circulating Tumor Cell (CTC) Diagnostics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
Japanese Demand Estimates and Forecasts for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2018 to 2025
Japanese Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Application: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
China
Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025
Chinese Circulating Tumor Cell (CTC) Diagnostics Retrospective Market Scenario in US$ Million by Technology: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025
Chinese Demand for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2018 to 2025
Circulating Tumor Cell (CTC) Diagnostics Market Review in China in US$ Million by Application: 2009-2017
Chinese Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Application: 2009 VS 2019 VS 2025
Europe
Market Facts & Figures
European Circulating Tumor Cell (CTC) Diagnostics Market: Competitor Market Share Scenario (in %) for 2018 & 2025
European Circulating Tumor Cell (CTC) Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Circulating Tumor Cell (CTC) Diagnostics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Circulating Tumor Cell (CTC) Diagnostics Market Assessment in US$ Million by Technology: 2018-2025
European Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Technology: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
European Circulating Tumor Cell (CTC) Diagnostics Addressable Market Opportunity in US$ Million by Application: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
European Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2009 VS 2019 VS 2025
France
French Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Projections in US$ Million by Technology: 2018-2025
French Circulating Tumor Cell (CTC) Diagnostics Historic Market Analysis in US$ Million by Technology: 2009-2017
French Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
Circulating Tumor Cell (CTC) Diagnostics Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
French Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Application: 2009-2017
French Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
Germany
German Circulating Tumor Cell (CTC) Diagnostics Latent Demand Forecasts in US$ Million by Technology: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017
German Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
Circulating Tumor Cell (CTC) Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
German Circulating Tumor Cell (CTC) Diagnostics Market in Retrospect in US$ Million by Application: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
Italy
Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025
Italian Circulating Tumor Cell (CTC) Diagnostics Retrospective Market Scenario in US$ Million by Technology: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025
Italian Demand for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2018 to 2025
Circulating Tumor Cell (CTC) Diagnostics Market Review in Italy in US$ Million by Application: 2009-2017
Italian Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Application: 2009 VS 2019 VS 2025
United Kingdom
United Kingdom Medium & Long-Term Outlook for Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Technology: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in the United Kingdom in US$ Million by Technology: 2009-2017
United Kingdom Circulating Tumor Cell (CTC) Diagnostics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
United Kingdom Demand Estimates and Forecasts for Circulating Tumor Cell (CTC) Diagnostics in US$ Million by Application: 2018 to 2025
United Kingdom Circulating Tumor Cell (CTC) Diagnostics Market in US$ Million by Application: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Market Assessment in US$ Million by Technology: 2018-2025
Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Technology: 2009-2017
Circulating Tumor Cell (CTC) Diagnostics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Addressable Market Opportunity in US$ Million by Application: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
Rest of Europe Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Estimates and Projections in US$ Million by Technology: 2018-2025
Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Historic Market Analysis in US$ Million by Technology: 2009-2017
Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
Circulating Tumor Cell (CTC) Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Historic Market Review in US$ Million by Application: 2009-2017
Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
Rest of World
Circulating Tumor Cell (CTC) Diagnostics Market Analysis in Rest of World in US$ Million by Technology: 2018-2025
Circulating Tumor Cell (CTC) Diagnostics Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2009-2017
Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
Circulating Tumor Cell (CTC) Diagnostics Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
Rest of World Circulating Tumor Cell (CTC) Diagnostics Market Share Analysis by Application: 2009 VS 2019 VS 2025
Total Companies Profiled : 43

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com